Education
About Us
Working with TipRanks
Follow Us
BiomX (PHGE)
:PHGE
PHGE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.34 - $1.81
Previous CloseN/A
Volume30.96K
Average Volume (3M)10.20M
Market Cap
$13.35M
Enterprise Value$27.08M
Total Cash (Recent Filing)$20.12M
Total Debt (Recent Filing)$9.29M
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Nov 13, 2025EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding26,533,888
10 Day Avg. Volume24,379,012
30 Day Avg. Volume10,198,016
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap2.03
Enterprise Value/Revenue307.78
Enterprise Value/Gross Profit11.60
Enterprise Value/Ebitda-3.70
Forecast
1Y Price Target
$15.00Price Target Upside2578.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Clinical Trial SuccessBiomX announced positive results from its Phase 2 trial of BX211 for diabetic foot osteomyelitis, demonstrating efficacy and promising outcomes.
Regulatory AdvancementThe company plans to meet with the FDA to discuss data and seek regulatory endorsement, potentially streamlining the approval pathway for BX004.
Bears Say
Investor SentimentInvestor sentiment was negative, which is likely due to the p-values for the key endpoints.
BiomX News
PHGE FAQ
What was BiomX’s price range in the past 12 months?
BiomX lowest stock price was $0.34 and its highest was $1.81 in the past 12 months.
What is BiomX’s market cap?
BiomX’s market cap is $13.35M.
When is BiomX’s upcoming earnings report date?
BiomX’s upcoming earnings report date is Nov 13, 2025 which is in 89 days.
How were BiomX’s earnings last quarter?
BiomX released its earnings results on Aug 13, 2025. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.26 by $0.07.
Is BiomX overvalued?
According to Wall Street analysts BiomX’s price is currently Undervalued.
Does BiomX pay dividends?
BiomX does not currently pay dividends.
What is BiomX’s EPS estimate?
BiomX’s EPS estimate is -0.32.
How many shares outstanding does BiomX have?
BiomX has 26,533,888 shares outstanding.
What happened to BiomX’s price movement after its last earnings report?
BiomX reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.26. Following the earnings report the stock price went down -10.714%.
Which hedge fund is a major shareholder of BiomX?
Currently, no hedge funds are holding shares in PHGE
Company Description
BiomX
BiomX Inc. (PHGE) is a clinical-stage microbiome company that focuses on the discovery and development of bacteriophage-based therapies. These therapies are designed to target and destroy harmful bacteria in the human body, particularly in diseases where the microbiome plays a significant role. The company's core products are aimed at conditions such as acne, inflammatory bowel disease (IBD), and primary sclerosing cholangitis (PSC), leveraging its proprietary microbiome discovery platform to identify and develop phage therapies.
PHGE Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant progress with positive clinical trial results and secured financing, although there was an increase in R&D expenses. Overall, the sentiment of the call is optimistic with a focus on future opportunities.View all PHGE earnings summariesPHGE Stock 12 Month Forecast
Average Price Target
$15.00
▲(2578.57% Upside)
Technical Analysis
Curis
―
Cellectar Biosciences
―
ABVC BioPharma
―
Bolt Biotherapeutics
―
SAB Biotherapeutics
―
Ownership Overview
10.71% Insiders
49.04% Other Institutional Investors
40.25% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---